Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/03/041375
CTRI/2022/03/041375
Completed
Phase 4

A Comparative Study to Evaluate the Efficacy and Safety of Chlorthalidone with Losartan versus Amlodipine with Losartan in Patients With Primary Hypertension

BMCRI0 sites80 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: I10- Essential (primary) hypertension

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Sponsor
BMCRI
Enrollment
80
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 30, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
BMCRI

Eligibility Criteria

Inclusion Criteria

  • •1\.Patient willing to give written informed consent
  • •2\.Patients who are diagnosed to be having Stage 2 hypertension as per JNC 8 guidelines

Exclusion Criteria

  • •1\.Patients having comorbidities like Chronic kidney disease, Stroke , Congestive Heart Failure, Myocardial infarction , Coronary Artery Disease, Psychiatric Disorders, Suspected Secondary Hypertension (Eg. Renal artery stenosis, Cushingââ?¬•s syndrome )
  • •2\.Pregnant and Lactating mothers
  • •3\.Patients with hypersensitivity to the study medications

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
A diabetic study to find the safety and efficacy of newer drug Imeglimin.Health Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2023/06/053822Dr Shaki Sam
Not yet recruiting
Phase 4
TO EVALUATE THE EFFICACY AND SAFETY OF TENELIGLIPTIN VERSUS VILDAGLIPTIN AS AN ADD-ON TO METFORMIN IN DIABETES
CTRI/2018/06/014353Praveen A
Not yet recruiting
Phase 4
To determine the efficacy and safety of injection Labetalol Versus tablet Nifedipine in patients of severe pre-eclampsiaHealth Condition 1: O141- Severe pre-eclampsia
CTRI/2024/07/071651DrRida Rizvi
Not yet recruiting
Phase 4
Efficacy of oral tranexamic acid and topical triple combination cream in treatment of melasmaHealth Condition 1: L814- Other melanin hyperpigmentation
CTRI/2024/04/065382MOHAN H
Not yet recruiting
Not Applicable
Comparison of efficacy and safety of Vortioxetine and Escitalopram in depressive patients.Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
CTRI/2023/12/060661Ronakkumar Chandubhai Patel